Osteopore specialises in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing.

Osteopore is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopaedic, and maxillofacial surgery use.

Osteopore products are made of a US FDA approved polymer called polycaprolactone (PCL). PCL is bioresorbable, malleable, slow-degrading and possesses mechanical strength similar to trabecular bone.


Brett Sandercock, Non Executive Chairman

Brett Sandercock was appointed chief financial officer of Resmed Limited (NYSE: RMD, ASX: RMD) in January 2006. Previously, he served as ResMed’s vice president of Treasury and Finance from November 2004 until December 2005, and group accountant and controller from 1998 to 2004.

read more

Professor Teoh Swee Hin, Non Executive Director

Professor Teoh is presently the Chairman, Singapore Academy, Asia Regulatory Professional Association (ARPA). He sits in as board of editors Tissue Engineering, Journal of Tissue Engineering and Regenerative Medicine, Journal of Mechanical Behaviour of Biomedical Materials, Journal of Oral & Maxillofacial Research and Proceedings of the Institution of Mechanical Engineers Part H: Journal of Engineering in Medicine.

read more

Stuart Carmichael, Non-Executive Director

Mr Carmichael also acts as Non-Executive Chairman of Schrole Ltd (ASX:SCL), Non-Executive Chairman of Serpentine Technologies Ltd (ASX:S3R), Non-Executive Director of De.mem Limited (ASX:DEM) and Non-Executive Director of ClearVue Technologies Limited (ASX:CPV).

read more

Geoff Pocock, Executive Director

Mr Pocock has a Bachelor of Science with first class honours and a Bachelor of Law from the University of Western Australia, and has completed a Postgraduate Diploma in Applied Finance and Investment from the Securities Institute of Australia. Mr Pocock previously spent several years as a research scientist in the biopharmaceutical industry in Australia and the United Kingdom.

Mr Pocock acts as Non-Executive Director of Emvision Medical Devices Limited (ASX:EM1).

read more